New Sugar-Tracking scan could reveal hidden inflammation

NCT ID NCT07253753

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early-phase study tests a new radioactive tracer called NeuCaVis in 12 healthy volunteers. Unlike standard PET scans that track glucose, NeuCaVis follows fructose, which is only used by inflamed tissues. The goal is to check safety and how the tracer spreads in the body, potentially leading to clearer images of disease in the brain and heart.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.

Contacts and locations

Locations

  • University of Ottawa Heart Institute

    Ottawa, Ontario, Canada